OGN vs STEM · P/E 3.4, rev $6.40B vs rev $144.6M
Organon & Co (OGN) versus Stem Inc (STEM) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Stem Inc (STEM) is a utilities - renewable company listed on US.
Latest reported OGN revenue for 2024-12-31 was $6.40B. Net income was $864.0M. Revenue was up 2.2% from 2023-12-31 to 2024-12-31. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported STEM revenue for 2024-12-31 was $144.6M. Net income was -$854.0M. Revenue was down 68.7% from 2023-12-31 to 2024-12-31. STEM currently screens at market cap $82.1M.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. STEM currently screens at market cap $82.1M.
Not investment advice. Open the OGN and STEM stock pages for the full models.
Not investment advice.